Home For Suppliers Academics Feedback Careers Contact Us
                     
About Us Our Departments International Patient Relations Health Check Commitment to Quality
     

Academics
KIMS INSTITUTE OF POSTGRADUATION |
KIMS INSTITUTE OF ALLIED HEALTH SCIENCES |
SOCOMER |
RESEARCH PROGRAMMES |
KIMS COLLEGE OF NURSING |
KIMS SCHOOL OF NURSING |
.........................................................................................................................................................
KIMS INSTITUTE OF POSTGRADUATION
THE NATIONAL BOARD OF EXAMINATIONS
The well accredited Diplomate of National Board programme is offered at KIMS in eleven specialties. MBBS holders with CET score are given admissions on the basis of merit and interview.
No Super - Specialty Eligibility Duration No.of seats Course Commencement
1 Cardiology MD, CET 3 years 1 January
2 Neonatology MD, CET 3 years 1 January

No Specialty Eligibility Duration No.of seats Course Commencement
1 Internal Medicine MBBS, CET 3 years 2 January
2 General Surgery MBBS, CET 3 years 2 January
3 Peadiatrics MBBS, DCH 2 years 2 January
MBBS, CET 3 years 2 January
4 Obstetrics & Gynaecology MBBS, DGO 2 years 2 January
MBBS, CET 3 years 2 January
5 Respiratory Diseases MBBS, DTCD 2 years 1 January
MBBS, CET 2 years 1 January
6 Orthopaedics MBBS, DO 2 years 1 January
MBBS, CET 3 years 1 January
7 ENT MBBS, DLO 2 years 1 January
MBBS, CET 3 years 1 January
8 Family Medicine MBBS 3 years 4 January
9 Radio Diagnosis MBBS, DMRD 2 years 1 July
MBBS, CET 3 years 1 July

Contact Details:
 Prof. K. P. Ravidas, Manager - Academic Affairs
Mob: 9447944725
Ph: 0471-3041849
E-mail ID: academics@kimskerala.com

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC)
This postgraduate programme is offered by the Indira Gandhi National Open University in 9 centers in India and KIMS is the only institution recognized to impart training in Kerala. This is a comprehensive two-year programme in Cardiology started in 2006 with an annual intake of six students with MBBS and two years experience and currently there are two batches under going training.
Contact Details:
Mr. M T Manoj , Executive-SOCOMER
Mob: 9744760964
Ph: 0471 3041424
E-mail ID: socomer@kimskerala.com
.........................................................................................................................................................
KIMS INSTITUTE OF ALLIED HEALTH SCIENCES
BACHELOR OF MEDICAL LABORATORY TECHNOLOGY
This Course is affiliated to the Sikkim Manipal University. BSc.MLT is a very useful course aimed at enhancing the quality of Laboratory Techniques which is an essential component in Clinical Services.
Eligibility: +2 Science with 50% marks
Duration: 4 years
Commencement of class: August - September
BACHELOR OF MEDICAL IMAGING TECHNOLOGY
Medical Imaging Technology is an emerging field of medicine with excellent job opportunities.
Eligibility: +2 Science with 50% marks
Duration: 4 years Commencement of
Class: August - September
BACHELOR OF HEALTH INFORMATION ADMINISTRATION
The growth of Information Technology and the policy changes in the health sector have made it absolutely necessary to produce a new breed of Medical Documentation professionals.  Apart from routine work, this course facilitates research activities as well. This field of hospital administration is found almost neglected or handled by people who have no professional expertise. Kerala Institute of Medical Sciences offers courses which includes medical transcription, coding for health insurance etc through this course.
Eligibility: +2 (any subject) with 50%
Duration: 4 Years
Commencement of class: August - September
DIPLOMA IN RADIOLOGICAL TECHNIQUES
Directorate of Medical Education, Government of Kerala, has sanctioned two courses in the academic year 2004. Diploma in Radiological Techniques (DRT) is focused on its vocational value and will provide employment opportunities and is very much needed in the present health scenario.
Eligibility: +2 Science with 50%
Duration: 2 Years
Commencement of class: December
DIPLOMA IN OPERATION THEATRE TECHNOLOGY.
This is a two-year Diploma Course conducted by the Directorate of Medical Education and is organized by the Department of Anaesthesia. The trainees will acquire adequate skill in all the services of the Operation Theatre. This is identified as another promising field of employment.
Eligibility: +2 Science with 50%
Duration: 2 ½ Years
Commencement of class: December
Contact Details:
Prof. K.P Ravidas Co-ordinator Academics
Ph: 0471 3041849, 9447944725 E-mail ID: academics@kimskerala.com
.........................................................................................................................................................
SOCOMER
ABOUT SOCOMER
Society for Continuing Medical Education and Research (SOCOMER) is a registered Society constituted exclusively for teaching, research and other academic activities. The SOCOMER is responsible for conducting Continuing Medical Education programmes, conferences, Seminars, Workshops, coaching for PLAB and PG entrance examinations. Regular training programs in ACLS, NALS, PLAS are also ongoing activities. Research activities and guidance for Research Projects, both for the KIMS staff, students and those of other institutes are unique feature of SOCOMER.
SOCOMER executive committee
No. Name Designation
1   Dr. G.Vijayaraghavan   President
2   Dr. M.I.Sahadulla   Vice-President
4   Prof. A.Joseph   Member Secretary
5   Dr. Mathew Chacko Ramacha   Member
6   Dr. K.N.Vijayan   Member
7   Dr. Narendranathan   Member
8   Dr. Sushama Devi   Member
9   Dr. Venugopal   Member
10   Dr. R.Jayakumar   Member
11   Dr. Satish Balan.   Member
12   Dr. Naveen Jain   Member
Composition of Institutional Human Ethical Committee is:
No. Name Designation
1.   Dr. M. R Sethuraj PhD, FNAAS   Chairman
2.   Dr. M. I. Sahadulla MD, FRCP (Lon),
  FRCP (Ire), MBA		   Vice Chairman
3.   Padmasree Prof. G. Vijayaraghavan
  MD, DM (Card), FRCP (Lond),FRCP (Edin),
  FACC, FAHA 		  Member Secretary
4.   Prof. A. Joseph M.Sc, FRES, D. Med En   Member
5.   Adv. P. A. Dev, LLB   Member & Legal Advisor
6.   Dr. Mathew Thomas MBBS, MD(Med.), FICP   Member
7.   Mrs. Lekha Sreenivasan Special
  B.Sc in Zoology		   Member & Social Worker
8.   Dr. M. N. Rema MD, DME (Retd)   Member & Pharmacologist
9.   Dr. T. N. Sugathan PhD   Member & Statistician
10.   Ms. Lalithambika MA, MBA, IAS (Retd)   Member & Social Worker
11.   Mr. Thalekkunnil Basheer MA, LLB   Member & Social Worker
12.   Adv. A. Abdul Kharim LLB   Member & Legal Advisor
13.   Mr. P. Vijayachandran IFE   Member & Layperson
Programmes conducted
  • PHONOCON 2010 -  6th Annual Conference of Association of Phonosurgeons of India,  15, 16 & 17 January 2010  
  • Clinical Club Meeting month for January, 28 Jan 2010
  • A New Bright Star In The Calcium Channel Blocker Horizon on 6th February  2010
  • Workshop on Neonatal Ventilation on 13th and 14th February  2010
  • Clinical Club Meeting month of February, 24 February 2010
  • Seminar on Confidential Deaths on Maternal Deaths, Kerala, on 7th  March 2010
  • Training program on “Protect the Protector” on 17th March 2010 
  • CME on “Epidemiology and Management of Fungal infections in Peadiatric Patients” on 18th March 2010
  • Seminar on “AIM-ESBL Educational Endeavour” on 19th March 2010
  • Workshop on “Research Methodology” on 27th March 2010
  • Conducted a Webcast on: “Kwik Lilly Diabetes Update” on 12th and 13th April 2010
  • AHA training course “BLS & ACLS” on 13th, 14th & 15th April 2010
  • Conducted National Clinical Cardiology Update 2010 on 24th and 25th April 2010
  • Indio Russian Epidemiological Meet on 3rd May 2010
  • KIMS – ALGONQUIN College Tie-up Meeting held on 17th, 18th and 19th May 2010
  • Clinical club meeting was organized on 21st May 2010
  • CME on “Protect the Protector” held on 25th May 2010.
  • CME on “Management Beyond Hypertension”  on 28th May 2010
  • The Ethical Committee Meeting held on 3rd June 2010
  • CME on “Lung Functioning Test” on 10th June 2010
  • Workshop on “Neonatal Resuscitation” on 13th June 2010
  • Research Committee meeting was held on 14th June 2010
  • CME on “Beating Heart Valve Surgeries for Multiple Valve Procedures, 17th. June 2010
  • CME on “Asthma Management” on 22nd.   June 2010
  • CME on”LDL TO HDL Ratio” on 25th. June 2010
  • CME on “Basic Laparoscopy “ on 26th and 27th June 2010
  • Clinical Club Meeting on 30th June 2010
  • PG Diploma in Intensive Cardiac Care Interview on 1st  and 14th July 2010
  • CME on “Protocol Development for Adult Vaccination” on 10th July 2010
  • CME on “Paradigm Shift in the Management of Hypertension” 21st July 2010
  •  PGDCC interview of new batch held on 28th July 2010
  • Clinical Club Meeting on 28th July 2010
  • Training Program for Nurses held on 6th  August 2010
  • CPE on “Ergonomics & Sports Physical Therapy” held on 08th  August 2010 
  •  BLS & ACLS held on 13th, 14th & 15th August 2010
  • KIMS Certified Course: PG Diploma in Intensive Cardiac Care, started on 16th August 2010
  • PGDCC Internal Practical Examination held on 20th August 2010
  • CME on “General Rheumatology” held on 20th    August 2010
  • Clinical Club Meeting of Internal Medicine on 31st  August 2010
  • Clinical Club Meeting for the Month of August held on 6th September 2010
  • Clinical Club Meeting of Cardiology Dept  held on 13th September 2010     
  • Training Program for the Pharmacy Staff held on 19th September 2010
  • PGDCC Term - End Practical Examination held on 25th September 2010
  • World Heart Day Medical Camp at Sai Gram on 26th   September 2010
  • Clinical Club Meeting for the month of September held on 28th September 2010
  • MRCP Excel Paces held on 1st, 2nd, 3rd & 4th October 2010
  • Good Nursing Practice training program on 5th October 2010
  • Workshop on “Stress Management Program” on 6th & 7th October 2010
  • Training Program for Pharmacy Staff held on 7th October 2010
  • Clinical  Club Meeting held  27th  October 2010
  • CME on “Pneumococcal Vaccine and its Relevance in Paediatric practice”   on 11th   November 2010
  • Live web cast on “ Antiplatelet Therapy New Era in AMI” on 12th November 2010 
  • A lecture session on “Communication Skills” on 23rd November 2010
  • Clinical  Club Meeting  on 24th  November 2010
  • CME on “PCI in NSTEMI” on 14th  December 2010  
  • Clinical  Club Meeting   on  22nd  December 2010 
  • Cardiology Clinical Club Meeting on 28th December 2010 
  • International CME on “Comprehensive Echo Doppler Evaluation Techniques   CEDET-2011”  on 7th, 8th & 9th   January 2011
  • Clinical  Club Meeting   on  26th January 2011
  • CME on “Rosuvastatin – Clinical Evidence in Dyslipidemia and Atherosclerosis” on 10th February 2011
  • CME on “DVT Prophylaxis” on 22nd February 2011
  • Clinical  Club Meeting held on  23rd February 2011
  • CME & Hands on Training on “Emergency Trauma Care” on 26th February 2011
  • CME on “Venous Disease” on 10th March 2011
  • Cardiology Clinical Club Meeting on 14th March 2011
  • Live Web Caste  on “Emerging Trends in Neonatal Care and Nutrition” on 15th March 2011
  • CME  on “Strategies to Combat Resistance and Improve Patient Outcomes” on 19th March 2011
  • Clinical  Club Meeting held on  23rd March 2011
  • CME on  “Revised National Tuberculosis Control Program (RNTCP)” on 25th   March 2011
Contact Details:
Mr. M T Manoj , Executive-SOCOMER
Mob: 9744760964
Ph: 0471 3041424
E-mail ID: socomer@kimskerala.com
.........................................................................................................................................................
RESEARCH PROGRAMMES

Clinical Research Projects
Institutional Human Ethical Committee - KIMS
Society for Continuing Medical Education and Research
1. POLYCAP Department of Cardiology
A randomized double blind controlled trail of the efficacy and safety of POLYCAP versus its components in subject with at least one additional cardio-vascular risk factor.
2. Ivabradine Department of Cardiology
"Evaluation of the anti-anginal efficacy and safety of oral administration of Ivabradine compared to placebo on top of a background therapy with a calcium antagonist (Amlodipine or Nifedipine) in patients with stable angina pectoris. A 6-week randomized double-blind parallel group international multicentric study."
3. RECOVER 1160.53 Department of Cardiology
 A phase III, randomized, multicenter, double blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism.
4. RE-MEDY (1160.47) Department of Cardiology
A phase III, randomized, multicenter, double blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism.
5. TAK- 442_202 - H7T-MC-TABY Department of Cardiology
A Phase 2, Double blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
6. PALLAS (EFC11405) Department of Cardiology
Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients with Permanent Atrial Fibrillation and Additional Risk Factors.
7. CLARIFY REGISTRY Department of Cardiology
Prospective Observation Longitudinal  Registry of patients with stable coronary artery disease.
8. 3163K1-200WW / GAP-486 Department of Cardiology
A safety and efficacy dose ranging study of GAP-486 in subject with Nonsustained Ventricular Tachycardia and Acute Ischemia
9. SONOMA 3 Department of Internal Medicine
Phase 3, Multicentre, Multinational open-label study to evaluate the safety and efficacy of alfimeprase in subjects with occluled central venous access devices
10. Ramiprill Department of Internal Medicine
A Randomized, double-mind, placebo-controlled multicenter, parallel study assessing the efficacy, safety and dose response of Ramiprill for the Treatment of Hypertension in children and Adolesents
11. Ramiprill Department of Internal Medicine
A phase III, double-blind, placebo-controlled study to determine the efficacy and safety of a low (50mg/day) and high (100mg/day) dose of Safinamide, as add-on therapy, in patients with idiopathic Parkinson's disease with motor fluctuations, treated with a stable dose of levodopa and who may be receiving concomitant treatment with stable doses of dopamine agonist and/or an anticholinergic" NW-1015/016/III/2006 & A phase III, double-blind, placebo-controlled, 12-month extension study to investigate the long-term efficacy and safety of a low (50mg/day) and high (100mg/day) dose of safinamide, as add-on therapy, in patients with idiopathic Parkinsons disease with motor fluctuations, treated with a stable dose of levodopa and who may be receiving concomitant treatment with stable doses of dopamine agonist and/or an anticholinergic NW-1015-018-III/2006
12. Ramiprill Department of Internal Medicine
A phase III, double-blind, placebo-controlled study to determine the efficacy and safety of a low (50mg/day) and high (100mg/day) dose of Safinamide, as add-on therapy, in patients with idiopathic Parkinson's disease with motor fluctuations, treated with a stable dose of levodopa and who may be receiving concomitant treatment with stable doses of dopamine agonist and/or an anticholinergic" NW-1015/016/III/2006 & A phase III, double-blind, placebo-controlled, 12-month extension study to investigate the long-term efficacy and safety of a low (50mg/day) and high (100mg/day) dose of safinamide, as add-on therapy, in patients with idiopathic Parkinsons disease with motor fluctuations, treated with a stable dose of levodopa and who may be receiving concomitant treatment with stable doses of dopamine agonist and/or an anticholinergic NW-1015-018-III/2006
13. CS0866AU301 Department of Internal Medicine
Dose Ranging study to evaluate the safety and efficacy of Olmesartan Medoxomil in Children and adolescents with Hypertension
14. SYR-322 Department of Internal Medicine
A multicenter, randomized, double-blind, placebo-controlled study to determine the efficacy and safety of the combination of SYR-322 (SYR110322) and Pioglitazone HCI (Actos) in subjects with Type 2 diabetics
15. Metaglidasen (MBX-102) M102-20509 Department of Internal Medicine
A phase 2/3, Randomized, Double-blind, Placebo and Active Comparator controlled, Parallel group, multicenter study to determine the safety and efficacy of Metaglidasen (MBX-102) in the treatment of Type 2 diabetics in patients sub optimally controlled on Insulin
16. SLE Department of Internal Medicine
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-BT), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE)
17. SYR-322 OLE-012 Department of Internal Medicine
A Long Term Open Label Extension study to investigate the long-term safety of SYR-110322 (SYR-322) in subjects with Type 2 Diabetes
18. SYR-322 OLE-012 Department of Internal Medicine
A 26-week treatment, multicenter, randomized, doubleblind,double dummy, placebo-controlled, adaptive,seamless, parallel-group study to assess the efficacy,safety and tolerability of two doses of indacaterol (selected from 75, 150, 300 & 600 μg o.d.) in patients with chronic obstructive pulmonary disease using blinded formoterol (12 μg b.i.d) and open label tiotropium (18 μg o.d.) as active controls.
19. HGS1006-C1057 Department of Internal Medicine
A Phase 3, Multi-Center, Randomized, Double Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-BT), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE).
20. 01-05-TL-322OPI-001 Department of Internal Medicine
A Multicenter, Randomised, Double-blind, Placebo-controlled study to determine the efficacy and safety of the combination of SYR-322 (SYR 110322) and Pioglitazone HCl (Actos) in subjects with Type 2 diabetics
18. 01-06-TL-322OPI-002 Department of Internal Medicine
A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of SYR-322 plus Pioglitazone HCL (Actos), SYR-322 Alone or Pioglitazone HCL Alone in Subjects with Type 2 Diabetes
21. 01-06-TL-322OPI-004 Department of Internal Medicine
A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of the addition of SYR-322 25mg versus Dose Titration from 30 mg to 45 mg of ACTOS® Pioglitazone HCl in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Control on a Combination of Metformin and 30mg of Pioglitazone HCI Therapy
22. CS0866-A-U-301 Department of Internal Medicine
Dose-Ranging study to evaluate the safety and efficacy of Olmesartan Medoxomil in Children and Adolescents with Hypertension
23. Department of Internal Medicine
A Randomized, Double-Blind Study Comparing the Efficacy And Safety of a fixed combination of fenofibrate and metformin vs metformin alone in patients with type 2 diabetes mellitus and dyslipidemia not appropriately controlled with a statin.
24. CSPA100A2301 Department of Internal Medicine
A 54-week, open-label, Multicenter study to assess the long-term safety and tolerability of the combination of Aliskerin 300mg/Amlodipine 10mg in patients with essential hypertension
25. 1218.16 Department of Internal Medicine
A randomised, double-blind, placebo-controlled parallel group efficacy and safety study of BI 1356 (5 mg administered orally once daily) over 24 weeks, in drug naive or previously treated (6 weeks washout) type 2 diabetic patients with insufficient glycaemic control
26. 1218.17 Department of Internal Medicine
A randomized, double-blind, placebo-controlled parallel group efficacy and safety study of BI 1356 (5 mg administered orally once daily) over 24 weeks in type 2 diabetic patients with insufficient glycaemic control despite metformin therapy
27. L0013CP Department of Internal Medicine
Efficacy of an early administration of L0013CP 10 mg/day versus placebo during 4 weeks in the treatment of infectious diseases induced arthritis painful symptoms. A multicentre, randomised, double blind, placebo controlled clinical trial in adult patients suffering from chikungunya fever
28. CSPP100A2332 Department of Internal Medicine
An eight week double blind parallel group Multicenter study to evaluate the efficacy and safety of the combination of Aliskiren/HCTZ (300/12.5Mg) and 300/25Mg) in combination with Aliskiren 300Mg in patients with essential hypertension not adequately responsible to Aliskiren 300Mg monotherapy
29. Daiichi Sankyo DU -176b-D-U305-HOKUSAI: Department of Internal Medicine
A phase lll, randomized, double-blind, double-dummy, parallel-group, multi-center, multi-national study for evaluation of efficacy and safety of (LMW) Heparin / Edoxaban versus (LMW) Heparin / Warfarin in subjects with symptomatic deep-vein thrombosis and /or pulmonary embolism.
30. Protocol Title: NAI114373 Department of Internal Medicine
A Phase lll International, Randomized, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of 300 mg or 600mg of Intravenous Zanamivir twice daily Compared to 75mg of Oral Oseltamivir twice daily in the Treatment of Hospitalized Adults and Adolescents with Influenza.
31. MK-0431-063-00 Department of Nephrology
A Multicenter, Randomized, Double-Blind, Study to Evaluate the efficacy and Safety of Sitagliptin versus Glipizide in patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Control
32. SPP301CRD15 Department of Nephrology
A randomized double blind, pacebo controlled, parallel group study to assess the effect of the endothelin receptor antagonist in doubling of serum creatinine, end stage renal or death in patient with type 2 diabetes mellitus and diabetic nephropathy
33.KHK-NESP-III-0709.  Dept of Nephrology
A Randomized, Open-Label, Two-arm, multicentric, Phase III, Comparative study between Novel Erythropoiesis Stimulating Protein (NESP) and Recombinant Human Erythropoietin(r-HuEPO) for treatment of Renal Anaemia in patients with Chronic Renal Failure(CRF) Receiving Hemodialysis. 
34. NN2211-1796. Department of Endocrinology
Effect Gycaemic control of once daily administration of Liraglutide in combination with Metformin versus Glimepiride in combination with metformin in subjects with type 2 diabetesm a 16-week randomized, double blind, double dummy, active control, 4armed, parallel group, multi centre, multi-national trial
35. F3Z-US-100V (b) Department of Endocrinology
The durability of Twice daily Insulin Lispro Low mixture compared to Once-daily Insulin Glargine in patients with type 2 diabetes and inadequate Glycemic control
36. F3Z-CR-IOPH Department of Endocrinology
Comparison of Insulin Lispro Low mixture with Insulin Glargine when initiating and intensifying insulin therapy as required in patients with Type 2 Diabetes who have inadequate Glycemic control on Oral antihyperglycemic Medication
37. CLAF237A23122 Department of Endocrinology
A Multicenter, Double Blind, Randomized, Parallel-Group Study to Demonstrate the Effect of 12 weeks tratment with initial combination of vildagliptin 100mg qd plus Metformin 1000mg bid as Compared to Metformin 1000mg bid in Drug-naïve Patients with Type 2 Diabetes
38. CLAF237A2338 Department of Endocrinology
A Multicenter, Double-Blind, randomized, active controlled study to compare the effect of 52 weeks treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily as add –on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy
39. IN 0901 INT Dept of Oncology
“Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation with a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients)”
.........................................................................................................................................................
KIMS COLLEGE OF NURSING
COURSE OFFERED - BSc. DEGREE IN NURSING
College of Nursing, KIMS was established in 2006. Our emphasis is on value education, intellectual and clinical training of the students so that they can excel in their nursing career. We believe in providing quality care to the sick with a holistic approach without distinction of caste, creed, colour or social status.
GENERAL INFORMATION:
The college is affiliated to The University of Kerala, Thiruvananthapuram and is recognized by the Indian Nursing Council and the Kerala Nurses and Midwives Council.
 
The college conducts a four-year BSc Nursing degree programme.
The college admits 50 students annually
The seats available for admission for first year BSc. (N) course is mainly categorized as seats to be filled by the Commission of Entrance Examination, Kerala and management seats to be filled by the management.
 
OBJECTIVES:
Acquire knowledge on theory and principles of nursing and allied subjects, which are involved in the delivery of comprehensive nursing practice.
 
Excellence in all fields of health care education.
Obtain health resources in the community and the country.
Uphold respect for life, from the moment of conception to its natural end.
Develop a genuine feeling of compassion for the patient and their family.
Participate as member of health team in the promotive, preventive and restorative health care delivery system of the country.
 
Meet the health needs of underserved areas of our country and our underprivileged brethren.
Acquire leadership qualities and skills in problem solving and decision-making at different levels of work and life.
 
Recognize the need for continued learning for their personal and professional development.
Practice ethical values in their personal and professional life.
Promote holistic approach in health care modalities.
Acquiring an exemplary steadfastness to principles and moral values.
Develop skills in applying scientific principles and knowledge in health care settings.
Demonstrate skill in research.
Demonstrate competency in teaching and administration.
Develop communication skills.
ELIGIBILITY
Academic:
Candidates seeking admission should satisfy the following requirements.
Candidates who passed PLUS TWO examination of the Board of Higher Secondary Education of Kerala or equivalent examination recognized by University Of Kerala with an aggregate of 50 % marks in Physics, Chemistry, Biology.
 
Candidates who passed their qualifying examination from outside the State of Kerala should produce the certificate of recognition and equivalency of qualifying examination from University of Kerala.
 
It is the responsibility of the candidate to ensure that the qualifying examination he/she has passed is recognized by the University Of Kerala as eligible qualification for admission for BSc. Nursing course.
 
The candidate should produce migration certificate if it is needed.
Age:
Candidate should complete 17 years of age on 31st December 2006.
No relaxation of the minimum age will be allowed.
How to Apply
The candidate who seeks admission at KIMS College of Nursing should submit an application in the prescribed form available from the office, KIMS College of Nursing, Thiruvananthapuram, on payment of Rs. 500/- (Rupees five hundred only) in person or on payment of Rs.550 /- (Rupees five hundred and fifty only) by post.
 
The candidate who seeks admission under the management quota in College of Nursing should appear for the entrance examination conducted by Government of Kerala.
 
The candidate admitted under NRI quota need not attend the entrance examination by Government of Kerala.
 
The application should reach the Principal, College of Nursing, KIMS, before the stipulated date. The date will be published in due course.
 
Incomplete application without requisite documents will not be entertained.
The following documents (photocopies) should be forwarded along with the application form:
  Attested copies of mark list.
  Certificate to prove date of birth.
  Conduct /Character certificate.
  Eligibility certificate.
  Transfer certificate.
  Two passport size photographs
  Self attested stamped envelope (8”x4”).
  Entrance examination merit certificate of Government of Kerala
  Medical fitness
ADMISSION
1. The candidate applying in management quota should appear for the Entrance examination conducted by Government of Kerala before interview and should be qualified by the above exam.
 
2. The candidate should produce the certificates in original during interview (Annexure I).
3. The list of selected candidates will be displayed on notice board of KIMS College of Nursing and also the selected candidates will be informed by post.
 
4. The decision of the management will be final.
5. The candidate admitted under NRI quota should pay the fees from the NRI account of relatives (father, mother, brother, sister cousin, uncle & aunt).
 
6. If any candidate discontinues the course, after the closing of admissions as notified by the Controller of Examination, the candidate has to pay the compensation for the remaining course and which will be decided by the management as per agreement.
 
7. At the time of joining, each student must undergo a physical examination by a clinical doctor of KIMS, and if found unfit, admission will be denied.
 
8. The candidate should sign a bond stating the rules and regulations and mandatory requirement on the time of admission.
 
STIPULATION
All selected candidates should undergo internship for a period of one year, as per curriculum from the date of successful completion of the Course. Violation of this condition shall entail payment of compensation as per the signed contract/Bond by the candidate concerned.
FACILITIES
Nursing Practice:
The entire KIMS Hospital complex with its various specialties is made available to the students for clinical experience.
 
The Institution is also affiliated to various reputed hospitals for the clinical experience (The Regional Cancer Center, Thiruvananthapuram, The Women and Children Hospital, Thycaud, The Mental Health Center, Peroorkada, General Hospital, Thiruvananthapuram ).
 
A well planned community development and extension center is provided for community health nursing experience.
 
Residence:
All selected candidates except male candidates are requested to reside in the hostel provided for their stay. However, principal has the discretion to decide about the students stay in the hostel or be made as day scholar.
Library:
A well equipped library with more than 1500 books including internet facilities is functioning under KIMS , College of Nursing including internet facilities. Books are to be used with extreme care.
Laboratories:
Well-equipped laboratory facilities, exclusively for College of Nursing are available in addition to the modern lab facilities of KIMS Hospital.
Medical Checkup:
A Health record is maintained in the College to monitor the physical and mental health of the students. Students should produce the health record whenever they consult doctors at KIMS.
CONTACT DETAILS
PRINCIPAL
KIMS COLLEGE OF NURSING P.B.No.1, Anayara P.O
Trivandrum – 695 029
Tel: +91 471 3041000
+91 471 3041140 / 43
E-mail: nursingcollege@kimskerala.com
.........................................................................................................................................................
KIMS SCHOOL OF NURSING
PURPOSE
The purpose of the General Nursing Programme is to prepare general nurse who will function as member of the health team beginning with competencies for first level Position in both hospital and community. The programme is geared to the health needs of the country, the community and the individual and it will serve as a basis for advanced study and specialization in Nursing it will assist nurses in their personal and professional development so that they make their maximum contribution to the society as individual citizens and nurse.
OBJECTIVES
The nurses completing this course will be able to;
1. Demonstrate awareness of and skills required in the Nursing process in the provision of health care and nursing of patients. They will be competent to :
 
 
Assess the nursing needs of individuals, families and communities throughout life, from birth to death.
 
Plan appropriate action to meet their needs through competent safe nursing care.
Take appropriate action to help people retain or sustain their best possible level of health in all its aspects.
 
Work with other members of the health team and community in promotion of health prevention of illness, restoration of health and rehabilitation.
 
2. Apply relevant knowledge from the humanities biological and behavioral science in carrying out health care and nursing activities and functions.
 
3. Show sensitivity and skill in human relationships and communication in her daily work.
4. Demonstrate skill in the use of problem solving methods nursing.
5. Gain knowledge of health resources in the community and the country
6. Demonstrate leadership skills in working with the health team, community and others in the provision of health care.
 
7. Demonstrate understanding of and commitment of professional behaviour.
8. Demonstrate awareness of the necessity of belonging to professional organizations.
9. Demonstrate ability in self-awareness, self-evaluation in personal and professional life.
10. Promotion of health precautions against illness, restoration of health and rehabilitation.
To achieve the objectives, Kerala Institute of Medical Sciences started General Nursing and Midwifery Course in January 2004 with an intake of 20 students. KIMS School of Nursing is recognized by the Kerala Nurses and Midwifery Council and Indian Nursing Council. Presently KIMS School of Nursing is functioning with 86 students.
FACILITIES FOR TRAINING OF STUDENTS:
Clinical: In KIMS, the students receive additional training from Doctors and other experts in all fields of medical care. They are trained to use the most modern ventilators, defibrillators and other equipment in various branches of health care system.
Faculty: The Faculty of KIMS School of Nursing is well qualified and experienced as per the norms of council. Faculties give guidance and supervision to students in various clinical areas.
Support: A library with a wide range of books and journals for reference and reading is available in the Nursing School premises. KIMS School of Nursing is furnished with modern laboratories like Nursing lab, Nutrition lab, Anatomy lab, Community lab and computer lab with internet connection. The students and staff receive training for basic life support every year.
Hostel: KIMS School of Nursing provides well arranged separate hostel for male and female students with adequate facilities for co-curricular activities as well. They are under the care of a resident tutor and warden.
ADMISSION
Admission process starts after the periodic KNC & INC Inspection and sanction Order;
Advertisement in two daily newspapers.
Issue of application forms.
Receipt of filled up application forms ( closing date 30 days from date of advertisement)
Scrutiny & Verification of application
Short listing according to the mark/grade obtained in the 10+2 level examination conducted the board for Higher Secondary examinations, with physics, Chemistry and Biology.
 
Personal interview with selection committee members.
Selection is according to the grade secured in personal interview and qualifying examinations percentage.
 
Admission is based on state Nursing Council norms.
Class commence in 1st working day of October.
Age - 17-27yrs
Co-curricular activities:
A student Nurses Association unit functions for the up-gradation of curricular and extracurricular activities. They actively participate in sports, games and arts competitions conducted by SNA in Zonal and state level. During the course, students also receive guidance to plan their carrier.
Achievements: For the 1st batch of students, we have achieved 100% success in the qualifying exams conducted by Kerala Nurses and Midwives Council, and of our students also secured the 1st rank in Kerala. All students have completed their course and have joined as staff nurses in KIMS Hospital.
CONTACT DETAILS
PRINCIPAL KIMS SCHOOL OF NURSING
P.B.No.1, Anayara P.O
Trivandrum – 695 029
Tel: +91 471 3041000, +91 471 3041872
E-mail: schoolofnursing@kimskerala.com
 
  Find Your
Doctor
  Get an
Appointment
  Get an
Opinion
  Corporates &
Insurance
 
 
Home | For Suppliers | Academics | Feedback | Careers | Contact Us | About Us | Our Departments | International Patient Relations | Health Check | Commitment to Quality